Hudson Bay Capital Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-104,754
Closed -$303K 1556
2026
Q1
$303K Buy
+104,754
New +$223K ﹤0.01% 1030
2025
Q3
Sell
-17,483
Closed -$21.2K 1520
2025
Q2
$21.2K Buy
+17,483
New +$25.4K ﹤0.01% 1306
2024
Q3
Sell
-916,527
Closed -$3.9M 975
2024
Q2
$3.9M Buy
916,527
+786,394
+604% +$7.66M 0.02% 421
2024
Q1
$1.92M Buy
130,133
+80,940
+165% +$1.22M 0.01% 457
2023
Q4
$473K Buy
+49,193
New +$340K ﹤0.01% 559
2019
Q4
Sell
-40,100
Closed -$512K 471
2019
Q3
$512K Buy
40,100
+100
+0.3% +$1.44K 0.01% 346
2019
Q2
$679K Sell
40,000
-60,100
-60% -$1.03M 0.02% 344
2019
Q1
$1.8M Buy
+100,100
New +$1.73M 0.02% 484

Other funds holding MGNX

Hudson Bay Capital Management's MGNX Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 104,754 shares — an estimated $303K sold.

Hudson Bay Capital Management first reported a position in MGNX in Q1 2019 and held it in 8 quarters. The position peaked at $3.9M in Q2 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 104,754 MacroGenics shares in Q2 2026, an estimated $303K.
  • Hudson Bay Capital Management first reported a position in MacroGenics in Q1 2019 and held it in 8 quarters.
  • Hudson Bay Capital Management's MacroGenics position peaked at $3.9M in Q2 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.